A detailed history of Tacita Capital Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Tacita Capital Inc holds 169 shares of NVO stock, worth $23,732. This represents 0.02% of its overall portfolio holdings.

Number of Shares
169
Previous 236 28.39%
Holding current value
$23,732
Previous $24,000 12.5%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $6,841 - $9,106
-67 Reduced 28.39%
169 $21,000
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $20,716 - $24,886
236 New
236 $24,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $317B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tacita Capital Inc Portfolio

Follow Tacita Capital Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tacita Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tacita Capital Inc with notifications on news.